| abstract |
The invention relates to a method for treating or preventing headaches, migraine, or cluster headache. Said method comprises jointly administering a therapeutically effective amount of a selected CGRP antagonist (A), a physiologically acceptable salt thereof or a hydrate of said salt, and a therapeutically effective amount of a second or third active antimigraine medical substance (B), particularly sumatriptan, zolmitriptan, or dihydroergotamine or a physiologically acceptable salt thereof. Also disclosed are the corresponding pharmaceutical compositions and the production thereof. |